A urine specimen is collected in a sterile specimen collection container and packaged in a prepaid FedEx or UPS overnight envelope. The specimen is overnighted to Excelsior Diagnostics where it is processed by PCR molecular testing and resulted the same day. When the test is positive, the identified bacteria is automatically submitted for Antibiotic Resistance (ABR) Screening, to identify the most effective antibiotic treatment as soon as possible.

Simple culture tests have limited specificity and sensitivity which allow unidentified pathogens to go undetected and “hide” and even flourish as antibiotics are administered. The unfortunate result of allowing undetected pathogens to go untreated is a vicious cycle of recurring UTIs. In contrast, Excelsior’s UTI PCR testing identifies 17 pathogens for comprehensive and conclusive results. Unlike legacy culture tests, Excelsior’s testing is not affected by current antibiotic use and eliminates the guesswork by automatically providing an Antibiotic Resistance (ABR) Panel on all positive results. This helps to reduce health costs, avoid hospitalizations, maintain responsible antibiotic stewardship and most importantly, provides immediate and targeted relief.